High-purified cannabidiol efficacy and safety in a cohort of adult patients with various types of drug-resistant epilepsies
This study showed no significant difference regarding the type of drug-resistant epilepsy and suggests that this treatment may be of interest for all types of drug-resistant epilepsy.PMID:37806886 | DOI:10.1016/j.neurol.2023.07.012 (Source: Revue Neurologique)
Source: Revue Neurologique - October 8, 2023 Category: Neurology Authors: M Perriguey M El Succar A Cl ément S Lagarde O Ribes X Dode S Rheims F Bartolomei Source Type: research
Innovative minimally invasive options to treat drug-resistant epilepsies
Rev Neurol (Paris). 2023 Oct 3:S0035-3787(23)01038-X. doi: 10.1016/j.neurol.2023.05.006. Online ahead of print.ABSTRACTDespite the regular discovery of new molecules, one-third of epileptic patients are resistant to antiepileptic drugs. Only a few can benefit from resective surgery, the current gold standard. Although effective in 50-70% of cases, this therapy remains risky, costly, and can be associated with long-term cognitive or neurological side effects. In addition, patients are increasingly reluctant to have a craniotomy, emphasizing the need for new less invasive therapies for focal drug-resistant epilepsies. Here, ...
Source: Revue Neurologique - October 5, 2023 Category: Neurology Authors: L Samalens C Courivaud J-F Adam E L Barbier R Serduc A Depaulis Source Type: research
Impact of physical activity, physical fitness and exercises on cognitive impairment in patients with multiple sclerosis: A review of evidence and underlying mechanisms
Rev Neurol (Paris). 2023 Oct 3:S0035-3787(23)01037-8. doi: 10.1016/j.neurol.2023.06.003. Online ahead of print.ABSTRACTCognitive impairment in persons with MS (pwMS) occurs commonly, early and independently of other clinical features of the disease. MS-related cognitive impairment is mainly characterized by weakening of information processing speed, working memory and episodic memory. Much evidence, based on both neuropsychological and neuroimaging outcomes, highlights successful cognitive rehabilitation interventions. In this context, promotion of physical activity and exercise training could be a dual, motor and cognitiv...
Source: Revue Neurologique - October 5, 2023 Category: Neurology Authors: B Lenne C Donze C Massot B Degraeve Source Type: research
Innovative minimally invasive options to treat drug-resistant epilepsies
Rev Neurol (Paris). 2023 Oct 3:S0035-3787(23)01038-X. doi: 10.1016/j.neurol.2023.05.006. Online ahead of print.ABSTRACTDespite the regular discovery of new molecules, one-third of epileptic patients are resistant to antiepileptic drugs. Only a few can benefit from resective surgery, the current gold standard. Although effective in 50-70% of cases, this therapy remains risky, costly, and can be associated with long-term cognitive or neurological side effects. In addition, patients are increasingly reluctant to have a craniotomy, emphasizing the need for new less invasive therapies for focal drug-resistant epilepsies. Here, ...
Source: Revue Neurologique - October 5, 2023 Category: Neurology Authors: L Samalens C Courivaud J-F Adam E L Barbier R Serduc A Depaulis Source Type: research
Impact of physical activity, physical fitness and exercises on cognitive impairment in patients with multiple sclerosis: A review of evidence and underlying mechanisms
Rev Neurol (Paris). 2023 Oct 3:S0035-3787(23)01037-8. doi: 10.1016/j.neurol.2023.06.003. Online ahead of print.ABSTRACTCognitive impairment in persons with MS (pwMS) occurs commonly, early and independently of other clinical features of the disease. MS-related cognitive impairment is mainly characterized by weakening of information processing speed, working memory and episodic memory. Much evidence, based on both neuropsychological and neuroimaging outcomes, highlights successful cognitive rehabilitation interventions. In this context, promotion of physical activity and exercise training could be a dual, motor and cognitiv...
Source: Revue Neurologique - October 5, 2023 Category: Neurology Authors: B Lenne C Donze C Massot B Degraeve Source Type: research
Innovative minimally invasive options to treat drug-resistant epilepsies
Rev Neurol (Paris). 2023 Oct 3:S0035-3787(23)01038-X. doi: 10.1016/j.neurol.2023.05.006. Online ahead of print.ABSTRACTDespite the regular discovery of new molecules, one-third of epileptic patients are resistant to antiepileptic drugs. Only a few can benefit from resective surgery, the current gold standard. Although effective in 50-70% of cases, this therapy remains risky, costly, and can be associated with long-term cognitive or neurological side effects. In addition, patients are increasingly reluctant to have a craniotomy, emphasizing the need for new less invasive therapies for focal drug-resistant epilepsies. Here, ...
Source: Revue Neurologique - October 5, 2023 Category: Neurology Authors: L Samalens C Courivaud J-F Adam E L Barbier R Serduc A Depaulis Source Type: research
Impact of physical activity, physical fitness and exercises on cognitive impairment in patients with multiple sclerosis: A review of evidence and underlying mechanisms
Rev Neurol (Paris). 2023 Oct 3:S0035-3787(23)01037-8. doi: 10.1016/j.neurol.2023.06.003. Online ahead of print.ABSTRACTCognitive impairment in persons with MS (pwMS) occurs commonly, early and independently of other clinical features of the disease. MS-related cognitive impairment is mainly characterized by weakening of information processing speed, working memory and episodic memory. Much evidence, based on both neuropsychological and neuroimaging outcomes, highlights successful cognitive rehabilitation interventions. In this context, promotion of physical activity and exercise training could be a dual, motor and cognitiv...
Source: Revue Neurologique - October 5, 2023 Category: Neurology Authors: B Lenne C Donze C Massot B Degraeve Source Type: research
Factors associated with patent foramen ovale-related stroke: SAFAS study
CONCLUSION: Patients in whom cryptogenic stroke is attributed to a significant PFO have a specific clinical and biological phenotype. Low levels of galectin-3 and osteoprotegerin may help identify patients with PFO-related strokes.PMID:37777437 | DOI:10.1016/j.neurol.2023.05.007 (Source: Revue Neurologique)
Source: Revue Neurologique - September 30, 2023 Category: Neurology Authors: T Pommier A Lafont R Didier L Garnier G Duloquin A Meloux Audrey Sagnard M Graber G Dogon G Laurent C Vergely Y B éjot C Guenancia Source Type: research
When neurological symptoms reveal hemolytic uremic syndrome: A case report
Rev Neurol (Paris). 2023 Sep 28:S0035-3787(23)01039-1. doi: 10.1016/j.neurol.2023.04.009. Online ahead of print.NO ABSTRACTPMID:37777438 | DOI:10.1016/j.neurol.2023.04.009 (Source: Revue Neurologique)
Source: Revue Neurologique - September 30, 2023 Category: Neurology Authors: C Sulowski S Hadidane F Sanderson F Bartolomei S Lagarde Source Type: research
Factors associated with patent foramen ovale-related stroke: SAFAS study
CONCLUSION: Patients in whom cryptogenic stroke is attributed to a significant PFO have a specific clinical and biological phenotype. Low levels of galectin-3 and osteoprotegerin may help identify patients with PFO-related strokes.PMID:37777437 | DOI:10.1016/j.neurol.2023.05.007 (Source: Revue Neurologique)
Source: Revue Neurologique - September 30, 2023 Category: Neurology Authors: T Pommier A Lafont R Didier L Garnier G Duloquin A Meloux Audrey Sagnard M Graber G Dogon G Laurent C Vergely Y B éjot C Guenancia Source Type: research
When neurological symptoms reveal hemolytic uremic syndrome: A case report
Rev Neurol (Paris). 2023 Sep 28:S0035-3787(23)01039-1. doi: 10.1016/j.neurol.2023.04.009. Online ahead of print.NO ABSTRACTPMID:37777438 | DOI:10.1016/j.neurol.2023.04.009 (Source: Revue Neurologique)
Source: Revue Neurologique - September 30, 2023 Category: Neurology Authors: C Sulowski S Hadidane F Sanderson F Bartolomei S Lagarde Source Type: research
Factors associated with patent foramen ovale-related stroke: SAFAS study
CONCLUSION: Patients in whom cryptogenic stroke is attributed to a significant PFO have a specific clinical and biological phenotype. Low levels of galectin-3 and osteoprotegerin may help identify patients with PFO-related strokes.PMID:37777437 | DOI:10.1016/j.neurol.2023.05.007 (Source: Revue Neurologique)
Source: Revue Neurologique - September 30, 2023 Category: Neurology Authors: T Pommier A Lafont R Didier L Garnier G Duloquin A Meloux Audrey Sagnard M Graber G Dogon G Laurent C Vergely Y B éjot C Guenancia Source Type: research
When neurological symptoms reveal hemolytic uremic syndrome: A case report
Rev Neurol (Paris). 2023 Sep 28:S0035-3787(23)01039-1. doi: 10.1016/j.neurol.2023.04.009. Online ahead of print.NO ABSTRACTPMID:37777438 | DOI:10.1016/j.neurol.2023.04.009 (Source: Revue Neurologique)
Source: Revue Neurologique - September 30, 2023 Category: Neurology Authors: C Sulowski S Hadidane F Sanderson F Bartolomei S Lagarde Source Type: research
Factors associated with patent foramen ovale-related stroke: SAFAS study
CONCLUSION: Patients in whom cryptogenic stroke is attributed to a significant PFO have a specific clinical and biological phenotype. Low levels of galectin-3 and osteoprotegerin may help identify patients with PFO-related strokes.PMID:37777437 | DOI:10.1016/j.neurol.2023.05.007 (Source: Revue Neurologique)
Source: Revue Neurologique - September 30, 2023 Category: Neurology Authors: T Pommier A Lafont R Didier L Garnier G Duloquin A Meloux Audrey Sagnard M Graber G Dogon G Laurent C Vergely Y B éjot C Guenancia Source Type: research
When neurological symptoms reveal hemolytic uremic syndrome: A case report
Rev Neurol (Paris). 2023 Sep 28:S0035-3787(23)01039-1. doi: 10.1016/j.neurol.2023.04.009. Online ahead of print.NO ABSTRACTPMID:37777438 | DOI:10.1016/j.neurol.2023.04.009 (Source: Revue Neurologique)
Source: Revue Neurologique - September 30, 2023 Category: Neurology Authors: C Sulowski S Hadidane F Sanderson F Bartolomei S Lagarde Source Type: research
